Provided herein are specific doses of, and dosing regimens for, using a HIF prolyl hydroxylase inhibitor in treating or preventing anemia, such as anemia secondary to or associated with chronic kidney disease, anemia secondary to or associated with non-dialysis dependent chronic kidney disease anemia associated with or resulting from chemotherapy, or anemia associated with AIDS.本發明提供使用HIF脯胺醯基羥化酶抑制劑治療或預防貧血的特定劑量及給藥方案,貧血諸如慢性腎病繼發性或相關性貧血、非透析依賴性慢性腎病繼發性或相關性貧血、化學療法相關或產生的貧血,或AIDS相關性貧血。